Intellia Therapeutics
AUDIT: Intellia: The Biological API & the Sepsis Pivot
Audit of Intellia Therapeutics' in-vivo CRISPR trials. Examining the MAGNITUDE Phase 3 data, the 'Sepsis Pivot', and the severe clinical solvency risks.
Intellia Therapeutics
Audit of Intellia Therapeutics' in-vivo CRISPR trials. Examining the MAGNITUDE Phase 3 data, the 'Sepsis Pivot', and the severe clinical solvency risks.
Tech Fail
Intellia promises a one-time genetic cure, but their CRISPR tech is like throwing a spanner in a Swiss watch. Unpacking the Ostrich Algorithm and spin.